Byotrol plc ("Byotrol or the Company")
Director Dealing
Byotrol plc, the AIM-quoted anti-microbial technology company, is pleased to announce that the Company was notified on 24 September 2020 that on that same day, Nic Hellyer, CFO of the Company, purchased 129,870 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 7.7p per Ordinary Share (the "Purchase").
Following the Purchase, Mr. Hellyer has an interest in 629,870 Ordinary Shares representing 0.0014% of the total voting rights of the Company.
Enquiries:
Byotrol plc
David Traynor - Chief Executive Officer
Nic Hellyer - Chief Financial Officer 01925 742 000
finnCap
Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500
Richard Chambers - ECM
Flagstaff Strategic and Investor Communications
Tim Thompson/Andrea Seymour/Fergus Mellon 020 7129 1474
This announcement is released by Byotrol plc and, prior to publication, the information contained herein was deemed to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Nic Hellyer |
2. |
Reason for the Notification |
|
a) |
Position/status |
Chief Financial Officer |
b) |
Initial notification/Amendment |
Initial |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Byotrol Plc |
b) |
LEI |
213800AJMTSTIPA59A34 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the Financial instrument, type of instrument |
ordinary shares of 0.25p each |
Identification code |
GB00B0999995 |
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
c) |
Price(s) and volume(s) |
129,870 Ordinary Shares at 7.7p |
d) |
Aggregated information: |
See 4c) above |
e) |
Date of the transaction |
24 September 2020 |
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |